3167 results for «3221»
3167 results
DCB in de novo lesions: new valid option?
20 May 2025 – From EuroPCR 2025
Explore the emerging role of drug-coated balloons (DCB) in treating de novo coronary lesions. This session discusses complexity management, comparisons with drug-eluting stents (DES), and the potential of DCBs as valuable alternatives, especially in high bleeding risk patients.
Innovative approaches to thrombus removal: redefining acute thromboembolic management in ACS
21 May 2025 – From EuroPCR 2025
Unlock cutting-edge strategies for thrombus removal in acute coronary syndrome (ACS) with this EuroPCR 2025 session. Understand the mechanisms behind microvascular obstruction and no-reflow phenomena, and why effective thrombus management is crucial. Review the latest clinical evidence, from the Cheetah study to the ongoing TACTIC randomised...
Integration of CT and IVUS for treatment of coronary artery disease in daily practice: from planning to drug-eluting therapy
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights how imaging can drive precision in modern PCI. From CT-guided planning to IVUS-guided drug-eluting balloon interventions, each presentation offers practical insights into optimising patient outcomes. Step-by-step approaches and recorded cases illustrate how to tailor tool and technique selection, while also addressing...
New diagnostic and therapeutical tools in the coronary field
21 May 2025 – From EuroPCR 2025
Explore the latest advancements in diagnostic and therapeutic tools in coronary interventions. This session covers a range of innovative topics including the prognostic impact of QFR-based complete versus incomplete revascularisation, hybrid perfusion quantification with cardiac CT and echocardiography, clinical validation of AI-assisted coronary angiography, national audit...
Hotline TAVI 2: outcomes with new and established devices
21 May 2025 – From EuroPCR 2025
Review outcomes of new and established TAVI devices through pooled analyses and multicenter studies. Topics include comparisons of balloon-expandable valves, intra- versus supra-annular self-expanding valves, and insights from the ACURATE IDE and ACURATE prime studies.
Imaging coronary artery disease – New frontiers
21 May 2025 – From EuroPCR 2025
Delve into new frontiers in imaging coronary artery disease, shifting focus from ischemia to plaque characteristics for revascularisation decisions. This session highlights the pivotal role of intracoronary imaging in understanding complex vessel anatomy and planning treatment, illustrated through detailed case studies showcasing unusual anatomies requiring tailored...
How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?
21 May 2025 – From EuroPCR 2025
Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.
TAVI in challenging cases: pushing the limits
21 May 2025 – From EuroPCR 2025
Navigate challenging TAVI cases with this focused session emphasizing valve-in-valve procedures in complex anatomical scenarios. Learn strategies for managing TAVI in patients with multivessel disease and impaired ventricular function, and optimize procedural planning using advanced imaging, access methods, and device selection through detailed case presentations and...
A journey into the ANOCA and INOCA dilemma
21 May 2025 – From EuroPCR 2025
Explore the complex clinical dilemma of ANOCA and INOCA with focus on angina endotypes, prognostic stratification, metabolic phenotype associations, and microvascular function assessment using indices such as microcirculatory resistance and microvascular resistance reserve.
Case-based learning on different aspects of transcatheter LAA closure
21 May 2025 – From EuroPCR 2025
Engage in case-based learning focused on transcatheter left atrial appendage (LAA) closure. This session covers safe transseptal puncture techniques, state-of-the-art standard LAA closure procedures, management of challenging LAA anatomies, and optimization of post-procedure antithrombotic therapy in high-risk patients.
Imaging-based strategies for complication management in STEMI
21 May 2025 – From EuroPCR 2025
Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.
Novel devices for edge-to-edge mitral repair
21 May 2025 – From EuroPCR 2025
Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.
Complication management during mitral TEER procedures
21 May 2025 – From EuroPCR 2025
Explore complex case scenarios of complication management during mitral TEER procedures. This session covers haemodynamic challenges, thrombotic events, device malfunctions, and rare embolisation incidents, providing practical insights into effective bailout techniques and procedural problem-solving.
DCB PCI: are we ready for complex de novo lesions?
21 May 2025 – From EuroPCR 2025
Evaluate the readiness of drug-coated balloon (DCB) therapy for complex de novo coronary lesions. This session reviews comparative outcomes of DCB versus drug-eluting stents (DES) across CHIP risk categories, impacts of diabetes, long-term follow-up data in calcified lesions and left main bifurcations, and treatment of in-stent...
TAVI for aortic regurgitation: on-label and off-label use
21 May 2025 – From EuroPCR 2025
This session reviews on-label and off-label applications of transcatheter aortic valve implantation (TAVI) for treating aortic regurgitation. Examine complex cases including TAVI in patients with aortic dissection, cardiogenic shock, and valve-in-valve interventions, highlighting innovative procedural approaches and bailout strategies.
Updates in transcatheter MVR
21 May 2025 – From EuroPCR 2025
This session provides a detailed overview of recent advances in transcatheter mitral valve replacement (TMVR). Examine outcomes from next-generation transcatheter heart valves, long-term clinical data from mitral valve-in-valve and valve-in-ring procedures, and explore innovative approaches including transseptal MVR with insights from global studies.
Management of high-risk left main lesion
21 May 2025 – From EuroPCR 2025
Focus on managing high-risk left main coronary lesions with this session featuring complex cases such as thrombotic lesions, calcified distal left main PCI with orbital atherectomy and IVUS guidance, and advanced stenting techniques. Learn practical approaches for challenging anatomical and clinical scenarios to optimize patient outcomes.
Cathlab harmony: building high-performance teams
21 May 2025 – From EuroPCR 2025
Discover strategies to build and maintain high-performance teams in the cathlab environment. This session outlines how to foster a collaborative culture, address toxic behaviors, and effectively train and integrate team members to enhance teamwork and procedural success in cardiovascular interventions.
Did danger shock change my practice?
21 May 2025 – From EuroPCR 2025
Reflect on how contemporary management of cardiogenic shock has evolved through this session. Review collaborative strategies, challenging clinical cases involving STEMI, multivessel disease, refractory shock, spontaneous coronary artery dissection, and the critical role of intracoronary imaging in guiding interventional decisions.
DES and bioadaptator technologies in contemporary practice
21 May 2025 – From EuroPCR 2025
Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...
